+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07008742

Study on Collecting Blood and Tumor Tissue Samples in Patients with Oncogene-Driven or Early-Stage Non-Small Cell Lung Cancer Undergoing Targeted or Neoadjuvant Immunotherapy

Led by Royal Marsden NHS Foundation Trust · Updated on 2025-06-15

100

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating the feasibility of collecting blood and viable lung cancer tissue samples from patients with specific types of non-small cell lung cancer NSCLC. This includes patients with stage IV mutation-driven NSCLC and patients with stage II-III NSCLC who are undergoing immunotherapy before surgery. The aim is to understand better the genetic markers and tumor characteristics that could improve future targeted therapies and responses to treatment. The study defines two main groups one with metastatic NSCLC starting new targeted therapy, including subgroups based on previous treatments, and another with early-stage operable NSCLC receiving immunotherapy before surgery. Viable tumor tissue is identified by the presence of living cancer cells, assessed by specialized pathology methods. The study spans four years with three years of recruitment and follow-up, followed by an additional year of follow-up, and final data analysis in the fifth year. Participants will provide paired blood and tissue samples at different points depending on their group and treatment stage. Researchers will assess the presence of viable tumor tissue, analyze genetic and protein markers related to disease progression and treatment response, and measure immune-related antibodies. The main outcome is the number of participants from whom paired samples of blood and viable tissue can be collected, with ongoing monitoring and data analysis throughout the study duration.

CONDITIONS

Brief Title

Feasibility Study of Tissue and Blood Collection in Oncogene-addicted and Neoadjuvantly Treated Non Small Cell Lung Cancer

Research Team

A

Ashling Henderson, Senior Clinical Trial Manager

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here